Abstract
The determination by Gouaux and co-workers of the three-dimensional (3D) structure of a construct corresponding to the ligand-binding domain (S1S2) of the iGluR2 ionotropic glutamate receptor subunit constitutes a breakthrough in glutamate receptor research. Since the first publication of an iGluR2 construct (S1S2I) in complex with kainate (1), a number of X-ray structures based on a slightly modified construct (S1S2J) have been reported, including the ligand-free apo form of the protein (2) and ligand—iGlur2 complexes involving antagonists as well as agonists. The ligands in these complexes include the agonists (S)-glutamate (Glu) (2), (S)-2-amino-3-hydroxy-5-methyl-4-isoxazolyl propionic acid (AMPA) (2), kainate (2), (S)-2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)-propionic acid (ACPA), (3), (S)-2-amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]propionic acid (2-methyltetrazolyl AMPA) (3), (S)-2-amino-3-(4-bromo-3-hydroxy-5-isoxazolyl) propionic acid (Br-HIBO) (3); and the competitive antagonists 6,7-dinitro-2,3-quinoxalinedione (DNQX) (2) and (S)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]-propionic acid (ATPO) (4). The structures of these ligands are shown in Fig. 1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong, N., Sun, Y., Chen, G.-Q., and Gouaux, E. (1998) Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature 395, 913–917.
Armstrong, N. and Gouaux, E. (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the G1uR2 ligand binding core. Neuron 28, 165–181.
Hogner, A., Kastrup, J. S., Jin, R., Liljefors, T., Mayer, M. L., Egebjerg, J., et al. (2002) Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the G1uR2 binding core. J. Mol. Biol. 322, 93–109.
Hogner, A., Greenwood, J. R., Liljefors, T., Lunn, M.-L., Egebjerg, J., Larsen, I. K., et al. (2002) Competitive antagonism of AMPA receptors by ligands of different classes: crystal structures of ATPO bound to the G1uR2 ligand-binding core, in comparison with DNQX. J. Med. Chem. 46, 214–221.
Coquelle, T., Christensen, J. K., Banke T. G., Madsen, U., Schousboe, A., and Pickering, D. S. (2000) Agonist discrimination between AMPA receptor subtypes. NeuroReport 11, 2643–2648.
Banke, T. G., Greenwood, J. R., Christensen, J. K., Liljefors, T., Schousboe, A., and Pickering, D. S. (2001) Identification of amino acid residues in GluR1 responsible for ligand binding and desensitisation. J. Neurosci. 21, 3052–3062.
Yu, S., Olson, R., Horning, M., Armstrong, N., Mayer, M., and Gouaux, E. (2002) Mechanism of glutamate receptor desensitization. Nature 417, 245–253.
Arinaminpathy, Y., Sansom, M. S. P., and Biggin, B. C. (2002) Molecular Dynamics simulations of the ligand binding domain of the ionotropic glutamate receptor G1uR2. Biophys. J. 82, 676–693.
McFeeters, R. L. and Oswald, R. E. (2002) Structural mobility of the extracellular ligand-binding core of an ionotropic glutamate receptor. Analysis of NMR relaxation dynamics. Biochemistry 41, 10472–10481.
Lunn, M.-L. (2002) From gene to crystal structure. PhD thesis, Royal Danish School of Pharmacy, Copenhagen.
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) Basic local alignment search tool (BLAST). J. Mol. Biol. 215, 403–410.
Schwede T., Diemand A., Guex N., and Peitsch M. C. (2000) Protein structure computing in the genomic era. Res. Microbiol.151, 107 - 112. http://www.expasy.ch/swissmod/SWISSMODEL.html.
Brehm, L., Greenwood, J. R., Nielsen, B., Egebjerg, J., Stensbol, T. B., Bräuner-Osborne, H., et al. (2003) (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohept[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the G1uR5 subtype of glutamate receptors. Synthesis, modelling and molecular pharmacology. J. Med. Chem. 46, 1350–1358.
Singh, J. and Thornton, J. M. (1992). Atlas of Protein Side-Chain Interactions, Vols. 1 and 2. IRL Press, Oxford, UK.
Campiani, G., Morelli, E., Nacci, V., Fattorusso, C., Ramunno, A., Novellino, E., et al. (2001) Characterization of the 1H-Cyclopentapyrimidine-2,4(IH,3H)-dione derivative (S)CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. J. Med. Chem. 44, 4501–4504.
Goodford, P. J. (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28, 849–857.
GRID version 20 (2002) Molecular Discovery Ltd., 4 Chandos Street, London, W1A 3AQ.
Vriend, G. (1990) A molecular modeling and drug design program. J. Mol. Graph. 8, 52–56.
Kizelsztein, P., Eisenstein, M., Strutz, N., Hollmann, M., and Teichberg, V. I. (2000) Mutant cycle analysis of the active and desensitized states of an AMPA receptor induced by willardiines. Biochemistry 39, 12819–12827.
Lampinen, M., Settimo, L., Pentikäinen, O. T., Jouppila, A., Mottershead, D. G., Johnson, M. S., and Keinänen, K. (2002) Discrimination between agonists and antagonists by the a-amino3-hydroxy-5-methyl-4-isoxazole propionoic acid selective glutamate receptor. A mutation analysis of the ligand-binding domain for G1uR-D subunit. J. Biol. Chem. 227, 41, 940 11, 947.
Pentikäinen, O., Settimo, L., Lampinin, M., Jouppila, A., Keinänen, K., and Johnson, M. S. (2002) Selective agonist binding of AMPA and kainate receptors. P21, Biomolecular Interactions, Molecular Graphics and Modelling Society, Bristol UK, 3–5 April.
Jensen, T. V., Jakobsen, K. B., Greenwood, J. R., and Johansen, T. N. (2002) Unpublished data.
Glide version 1.8 (2002) Schrödinger, Inc., 1500 S.W. First Avenue, Suite 1180 Portland, OR 97201.
Rarey, M., Kramer, B., Lengauer, T., and Klebe G. (1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261, 470–489.
Jones, G., Willett, P., and Glen, R. C. (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245, 43–53.
Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olsen, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639–1662.
Muegge, I. and Rarey, M. (2001) Small molecule docking and scoring in Rev. Comput. Chem. Vol. 17, (Lipkowitz, K. and Boyd, D. B., eds.) Wiley-VCH, John Wiley and Sons, Inc., New York, NY, pp. 3–60.
Jacobsen, L. (2002) Ligand docking to iGluR2 and PPARy. Evaluation of the docking program Glide and comparisons with FlexX and GOLD. Master’s Thesis, Royal Danish School of Pharmacy, Copenhagen.
Stensbol, T. B., Ulmann, P., Morel, S., Eriksen, B. L., Felding, J., Kromann, H., et al. (2002) Novel 1-hydroxyazole bioisosteres of (S)-glutamic acid; synthesis, proteolytic properties and pharmacology. J. Med. Chem. 45, 19–31.
Johansen, T. N., Greenwood, J. R., Frydenvang, K., Madsen, U., and Krogsgaard-Larsen, P. (2003). Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors. Chirality, 15, 167–179.
Johansen, T. N., Janin, Y. L., Nielsen, B., Frydenvang, K., Bräuner-Osborne, H., Stensbol, T. B., et al. (2002) 2-Amino-3-(3-hydroxy-1,2,5-thiadiazol-4-yl)propionic acid: resolution, absolute stereochemistry and enantiopharmacology at glutamate receptors. Bioorg. Med. Chem. 10, 2259–2266.
Pickering, D. S. (2002) Unpublished data.
Ebert, B., Lenz, S. M., Brehm, L., Bregnedal, P., Hansen, J. J., Frederiksen, K., et al. (1994) Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(—)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol4-yl)propionic acid [(R,S)-APPA]. J. Med. Chem. 37, 878–884.
Stensbol, T. B., Jensen, H. S., Nielsen, B., Johansen, T. N., Egebjerg, J., Frydenvang, K., and Krogsgaard-Larsen, P. (2001) Stereochemistry and molecular pharmacology of (S)thio-ATPA, a new potent and selective G1uR5 agonist. Eur. J. Pharmacol. 411, 245–253.
Vogensen, S. B., Jensen, H. S., Stensbol, T. B., Frydenvang, K., Bang-Andersen, B., Johansen, T. N., et al. (2000) Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent G1uR3- and G1uR4-preferring AMPA receptor agonist. Chirality 12, 705–713.
Stensbol, T. B., Madsen, U., and Krogsgaard-Larsen, P. (2002) The AMPA receptor binding site: focus on agonists and competitive antagonists. Curr. Pharm. Design 8, 857–872.
Bleakman, R., Schoepp, D. D., Ballyk, B., Bufton, H., Sharpe, E. F., Thomas, K., et al. (1996) Pharmacological discrimination of G1uR5 and G1uR6 kainate receptor subtypes by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid. Mol. Pharmacol. 49, 581–585.
Greenwood, J. R. and T. Liljefors, T. (2001) Using the new X-ray crystal structures of ionotropic glutamate neuroreceptor subunit ligand-protein complexes for understanding subtype selectivity. Molecular Graphics and Modelling Society, Model(l)ing 2001, Erlangen, Germany.
Jane, D. E., Hoo, K., Kamboj, R., Deverill, M., Bleakman, D., and Mandelzys, A. Synthesis of willardiine and 6-azawillardiine analogues: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J. Med. Chem. 40, 3645–3650.
Hogner, A. (2002) AMPA receptor activation and deactivation: a study of protein—ligand interactions of the G1uR2 ligand binding core by X-ray crystallography. PhD thesis, Royal Danish School of Pharmacy, Copenhagen.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Greenwood, J.R., Liljefors, T. (2004). Computational Studies of Ligand-Receptor Interactions in Ionotropic Glutamate Receptors. In: Schousboe, A., Bräuner-Osborne, H. (eds) Molecular Neuropharmacology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-672-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-59259-672-0_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-384-8
Online ISBN: 978-1-59259-672-0
eBook Packages: Springer Book Archive